Posted by Michael Wonder on 30 Mar 2023
Expanded access to subsidised oral antiviral Paxlovid and other COVID-19 supports
30 March 2023 - From 1 April, more than 160,000 people aged 60 to 69 will have access to the antiviral treatment Paxlovid as the Albanese Government expands eligibility under the PBS.
The change was recommended by the independent PBAC and means Australians in this age group with only one risk factor for severe illness – instead of two – will get access to PBS subsidised Paxlovid.
